Back to dashboard
Episode 85
DIP Episode 85 - USMLE Step 1 Hematology Review Part 6 (Final)
HematologyMedium4 - HighHas Q&A
Step 1Step 2Step 3MedicineUSMLEStep 1Step 2Step 3
Topic
Hereditary Spherocytosis; Coombs Test (Direct vs. Indirect); Hemolytic Anemias (Intra- vs. Extravascular); Paroxysmal Nocturnal Hemoglobinuria (PNH)...
Key Takeaway
The clinical presentation of hemolytic anemia requires differentiating between extravascular hemolysis (macrophage destruction, unconjugated hyperbilirubinemia) and intravascular hemolysis (complement activation, haptoglobin consumption), while understanding the specific complement deficiencies underlying PNH and the genetic basis of SCD.
Runtime: 34.1 min
Published: 2019-03-10
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: HEME-ONC
Episode Notes
Source / episode info
- Episode: 85
- Title: Divine Intervention Episode 85 – USMLE Step 1 Hematology Review Part 6 (Final)
- Published: 2019-03-10
- Source: Episode page
One-liner
High-yield summary
- Hereditary Spherocytosis: Characterized by red blood cells lacking central pallor due to membrane protein defects (Spectrin, Band 3, Ankyrin). Diagnosis involves osmotic fragility testing; MCHC is typically elevated.
- Coombs Test Distinction: The Direct Coombs test detects antibodies already bound to the RBC surface (used for autoimmune hemolytic anemia); the Indirect Coombs test detects free antibodies in the serum that could bind to a donor's blood (screening).
- Hemolysis Types: Intravascular hemolysis is associated with complement activation, leading to low haptoglobin and schistocytes; Extravascular hemolysis occurs primarily in macrophages of the reticuloendothelial system.
- Paroxysmal Nocturnal Hemoglobinuria (PNH): An acquired disorder caused by a mutation in the {PIGA} gene, resulting in deficiency of GPI-anchored proteins ({CD}55 and {CD}59), leading to uncontrolled complement lysis.
Learning objectives
- Differentiate the pathophysiology and diagnostic tests for hereditary spherocytosis versus other hemolytic anemias.
- Interpret the results of Direct vs. Indirect Coombs tests to determine the source and type of autoantibody.
- Classify different types of hemolysis (intravascular vs. extravascular) based on laboratory findings (\text{haptoglobin}, schistocytes, bilirubin).
- Understand the complement cascade deficiencies associated with PNH and its management.
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Hereditary Spherocytosis | Red cells lacking central pallor; Elevated MCHC | Spectrin, Ankyrin, Band 3 defects | Think osmotic fragility test and pigment gallstones. |
| Paroxysmal Nocturnal Hemoglobinuria (PNH) | Thrombosis, Hemolysis, Low {CD}55/{CD}59 | {PIGA} gene mutation; Complement deficiency | Treatment involves C5 blockade ({Eculizumab}). |
| Sickle Cell Disease (SCD) | Vaso-occlusion; Dactylitis in infants | -globin chain Glu -> Val substitution | Remember the severity order: {HbSS} is worst. |
| Coombs Test | Direct vs. Indirect testing | Autoimmune Hemolytic Anemia (AIHA) | Direct = on RB Cs; Indirect = in serum. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| Hereditary Spherocytosis | Membrane protein defects ({Spectrin}, {Ankyrin}) cause loss of membrane surface area. | Leads to spherocytes and increased MCHC; susceptible to osmotic lysis. | High yield for physical exam/blood smear questions. |
| Direct Coombs Test | Detects antibodies bound to the RBC membrane. | Used in Autoimmune Hemolytic Anemia (AIHA). Positive result confirms antibody binding. | Crucial distinction from Indirect test. |
| Intravascular Hemolysis | Occurs within the circulation; involves complement activation. | Characterized by low {haptoglobin} and schistocytes ({DIC}, PNH, {PTG}). | Low haptoglobin is a hallmark of intravascular destruction. |
| PNH Pathophysiology | Deficiency of GPI-anchored proteins ({CD}55, {CD}59) due to {PIGA} mutation. | Allows uncontrolled complement attack on RB Cs, leading to hemolysis and thrombosis. | Remember the treatment is C5 blockade (Eculizumab). |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A young child presents with recurrent episodes of painful swelling in the metacarpals and metatarsals. | Sickle Cell Disease (SCD) - Dactylitis | Dactylitis is one of the most common initial presentations of SCD, due to vaso-occlusion in the small bones. |
| A patient has a history of chronic hemolysis, recurrent gallstones, and elevated MCHC on blood smear. | Hereditary Spherocytosis | The combination of spherocytes (leading to increased surface area/MCHC) and subsequent pigment gallstones is classic for HS. |
| A patient with unexplained hemolytic anemia requires screening before a massive transfusion. | Indirect Coombs Test | This test screens the recipient's serum for potential antibodies that could react against donor blood, preventing an acute transfusion reaction. |
| A patient presents with microcytic anemia and signs of atypical pneumonia in a non-immunocompromised setting. | Mycoplasma pneumoniae Pneumonia | M. pneumoniae is classically associated with IgM/cold autoimmune hemolysis (and sometimes mild cold agglutinin disease). |
| A patient develops recurrent thrombotic events, hemolytic anemia, and has low {CD}55 and {CD}59. | Paroxysmal Nocturnal Hemoglobinuria (PNH) | These three findings form the classic triad of PNH, driven by complement regulatory protein deficiencies. |
| A patient with SCD presents to the ED with fever, chest pain, and infiltrates on CXR. | Acute Chest Syndrome (ACS) | ACS is a common and potentially fatal complication in adults with SCD, resulting from pulmonary vaso-occlusion. |
Differential diagnosis / distinguishing features
Autoimmune Hemolytic Anemia (AIHA)
| Key Features | Distinguishing Findings | Next Step |
| Direct Coombs Test Positive | Antibodies are bound to the RBC surface; often IgG-mediated ("warm"). | Confirm AIHA and determine underlying cause (e.g., Lupus, drugs). |
| Indirect Coombs Test Positive | Free antibodies detected in serum; potential for reaction with donor blood. | Screen recipient before transfusion; suggests systemic antibody production. |
Hemoglobinopathies
| Key Features | Distinguishing Findings | Next Step |
| Sickle Cell Disease ({HbSS}) | -globin Glu -> Val substitution; Vaso-occlusion, Dactylitis, ACS. | Electrophoresis shows only {HbS}; Hydroxyurea increases protective {HbF}. |
| Hemoglobin C Disease | -globin Glu -> Lys substitution; Generally less severe than SCD. | Electrophoresis shows {HbC} peak; Compound heterozygotes ({HbSC}) are generally asymptomatic. |
Management pearls
- For suspected PNH, the definitive treatment is Eculizumab (a monoclonal antibody targeting C5), which blocks complement activation.
- In SCD, Hydroxyurea therapy is standard care as it increases \text{HbF} synthesis, reducing sickling and improving outcomes.
- When managing a patient with severe hemolysis, monitor for signs of acute kidney injury due to hemoglobinuria (red urine) and manage potential gallstone formation.
- If the Coombs test is positive, consider treating underlying autoimmune conditions (e.g., corticosteroids for lupus flare).
Don't miss
🚨
PNH: The \text{PIGA} mutation leads to defective GPI anchor synthesis, causing loss of protective proteins like \text{CD}55 and \text{CD}59.
🚨
SCD Complications: In children, dactylitis is common; in adults, Acute Chest Syndrome (ACS) is the most feared complication.
🚨
Complement Cascade: The deficiency of \text{CD}55 prevents the formation of the C3 convertase, and the deficiency of \text{CD}59 prevents the Membrane Attack Complex (\text{MAC}).
🚨
Sickle Cell Severity Order: Always remember that \text{HbSS} is the most severe genotype.
Integration & clinical reasoning
- The complement pathway (C5 blockade by Eculizumab) links hematology (PNH) with immunology and pharmacology.
- Hemolysis leads to increased bilirubin load, linking hematology to gastroenterology (pigmented gallstones).
- Vaso-occlusion in SCD is a systemic problem that affects multiple organs (spleen infarction -> autosplenectomy; mesenteric artery thrombosis).
Concept connections / cross-references
- The concept of complement deficiency and monoclonal antibody therapy relates to the management principles discussed in [Episode 12] (e.g., Eculizumab for atypical sepsis/meningitis).
- Understanding autoimmune sequelae, such as lupus nephritis or AIHA, connects with general rheumatology concepts covered in [Episode 45].
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Hereditary Spherocytosis | Spectrin, Ankyrin, Band 3 defects | Defects in the red blood cell cytoskeleton membrane proteins. | Leads to loss of surface area and subsequent splenic trapping/destruction. |
| Paroxysmal Nocturnal Hemoglobinuria (PNH) | {PIGA} gene mutation; Complement deficiency ({CD}55, {CD}59) | Loss of complement regulatory proteins allows uncontrolled complement lysis. | High risk for thrombosis and severe hemolysis; requires C5 blockade. |
| Sickle Cell Disease (SCD) | -globin Glu -> Val substitution | Polymerization of deoxygenated hemoglobin ({HbS}) causes rigid, sickling cells. | Leads to chronic vaso-occlusion syndrome affecting multiple organs. |
| Autoimmune Hemolytic Anemia (AIHA) | Warm autoimmune hemolysis (IgG); Lupus; Drugs (e.g., Methyldopa) | Antibodies bind directly to the RBC surface, marking them for splenic destruction. | Requires distinguishing between direct and indirect Coombs test results. |
Key terms glossary
| Term | Definition | Context | Example |
| Spherocyte | Small, dense red blood cell lacking central pallor. | Seen in Hereditary Spherocytosis; indicates membrane instability. | Blood smear finding suggestive of HS. |
| Osmotic Fragility Test | Measures the susceptibility of spherocytes to lysis in hypotonic solutions. | Diagnostic test for Hereditary Spherocytosis. | Increased hemolysis rate compared to normal cells. |
| Haptoglobinemia | Plasma protein that binds free hemoglobin released during intravascular hemolysis. | Levels drop significantly when massive red blood cell breakdown occurs. | Low haptoglobin strongly suggests intravascular hemolysis (e.g., {DIC}, PNH). |
| {PIGA} Gene | Gene responsible for synthesizing the GPI anchor required for complement regulatory proteins ({CD}55, {CD}59). | Mutation leads to Paroxysmal Nocturnal Hemoglobinuria (PNH). | Defective synthesis of surface-bound protective molecules. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Hemolytic Anemias | Create a flow chart comparing HS, AIHA, PNH, and SCD based on mechanism/test results. | High (Board staple) | Review blood smear images; memorize the {CD}55/{CD}59 roles. |
| Coombs Testing | Practice interpreting Direct vs. Indirect test results in clinical scenarios. | Medium-High | Focus on the purpose of each test (screening vs. diagnosis). |
| Hemoglobinopathies | Memorize the severity ranking ({HbSS} > {HbC} homozygous) and associated complications for SCD. | High | Use mnemonics for SCD complications: Dactylitis, ACS, Sepsis. |
Question pattern recognition
- The "Classic Triad" Pattern: Identifying a constellation of findings (e.g., \text{PNH}: thrombosis + hemolysis + low \text{CD}59).
- Differential Diagnosis by Morphology/Test: Using blood smear findings (\text{spherocytes} vs. \text{schistocytes}) and lab values (\text{MCHC}, haptoglobin) to narrow the diagnosis.
- Genetic Defect Pattern: Linking a specific gene mutation (\text{PIGA}, \beta-globin) to a systemic disease (PNH, SCD).
Test yourself
Common mistakes to avoid
🚫
Mistake 1: Confusing HS and AIHA. Remember that while both cause spherocytosis, HS is a structural/cytoskeletal defect, whereas AIHA involves antibody coating of the RB Cs.
🚫
Mistake 2: Misinterpreting Coombs Tests. Do not confuse Direct (on cell) vs. Indirect (in serum). The indirect test is used for screening before transfusion.
🚫
Mistake 3: Assuming all hemolysis is due to complement. While PNH involves complement, other causes of intravascular hemolysis exist (\text{DIC}, \text{TTP}).
Common traps
⚠️
Trap 1: Thinking the Coombs Test detects antibodies in the serum (Indirect) when it actually detects those bound to the cell (Direct). The Direct test is more specific for diagnosing AIHA.
⚠️
Trap 2: Assuming all hemolytic anemia causes low haptoglobin. Low haptoglobin strongly suggests intravascular hemolysis; if only extravascular, levels may be normal or mildly decreased.
⚠️
Trap 3: Believing that \text{HbSC} disease is asymptomatic. While much milder than SCD, it can still present with complications and requires monitoring.
OMM / COMLEX integration
🦴
High-Yield Viscerosomatics, Autonomics & COMAT Shelf Clinical Pearls:
- Spleen & Reticuloendothelial Innervation (T5–T9): The spleen and bone marrow microvasculature are influenced by sympathetic outflow from the celiac plexus (T5–T9, left side). Somatic dysfunction at the mid-thoracic paraspinal levels reflects splenic hematologic stress.
- Lymphatic Return in Malignancy & Lymphedema: Post-surgical or post-radiation lymphedema requires gentle proximal-to-distal decongestion starting with opening the thoracic inlet and axillary fascial diaphragms before addressing peripheral extremities. Avoid vigorous direct pumping over known active tumor sites.
- Bone Marrow Pain & Myofascial Somatic Dysfunction: Patients with hematologic expansion or skeletal metastases develop reactive hypertonicity in surrounding postural stabilizers (quadratus lumborum, erector spinae). Gentle indirect techniques (counterstrain, myofascial release) provide substantial pain relief without risking pathologic fractures.